コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 PTSD symptoms, particularly in those with no acute symptoms.
2 because most people infected do not develop acute symptoms.
3 continuous stimulation is better at limiting acute symptoms.
4 ith more prodromal symptoms experienced more acute symptoms.
5 regimen 16 hours later to improve control of acute symptoms.
6 ion, the patient underwent urgent CT for his acute symptoms.
7 oncologic diagnosis, treatment history, and acute symptoms.
8 olution was 89.9% (95% CI, 88.7%-90.9%) with acute symptoms.
9 tion(s), and it increased with the number of acute symptoms.
10 gative SARS-CoV-2 test result at the time of acute symptoms.
11 n whom PAMM is detected incidentally without acute symptoms.
12 comorbid conditions, COVID-19 diagnosis, and acute symptoms.
13 patients with (1) erythema migrans rash and acute symptoms, (2) post treatment Lyme disease syndrome
17 hancing peroxisome biogenesis mitigated both acute symptoms and post-acute sequelae of COVID-19 (PASC
18 he findings suggest that evaluating specific acute symptoms and signs may contribute to the prognosis
19 y clinical descriptors such as the number of acute symptoms and the pattern of their erythema migrans
20 cting beta2-agonists provide rapid relief of acute symptoms, but maintenance with daily inhaled corti
26 ple sclerosis, all of whom were experiencing acute symptoms, from seven patients with DNO, and from s
28 d from pigeon fanciers, 20 with intermittent acute symptoms indicative of developing HP, 27 with no s
29 of myelin that governs the progression from acute symptoms into disease remission, relapse, and chro
39 hdrawal trial of rilonacept in patients with acute symptoms of recurrent pericarditis (as assessed on
41 randomised controlled trials in adults with acute symptoms of schizophrenia or related disorders.
47 e mechanisms underlying these incapacitating acute symptoms remain partially understood, the progress
48 al was to examine suicidality in relation to acute symptom remission in inpatients with mixed and pur
50 other clinically indicated imaging (eg, for acute symptoms, short-interval treatment monitoring, urg
51 and comprised adults (aged >=18 years) with acute symptoms suggestive of SARS-CoV-2 infection at the
52 cipants were adults aged 18 to 64 years with acute symptoms suggestive of SARS-CoV-2 infection who re
54 so observe two outcomes in infected animals: acute symptoms that is associated with CAUTI and chronic
55 epitope spread, governs the transition from acute symptoms through remission, relapse, and chronic d
56 ntidepressant therapy following remission of acute symptoms to allow more complete resolution of the
57 bidities necessitating medication to relieve acute symptoms was 17% (16 patients) for rectal and 36%
63 ents with ovarian or adnexal lesions without acute symptoms who may have been managed conservatively